Correlation Between BioInvent International and Nykode Therapeutics

Can any of the company-specific risk be diversified away by investing in both BioInvent International and Nykode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Nykode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioInvent International AB and Nykode Therapeutics ASA, you can compare the effects of market volatilities on BioInvent International and Nykode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Nykode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Nykode Therapeutics.

Diversification Opportunities for BioInvent International and Nykode Therapeutics

0.62

Correlation Coefficient

BioInvent International  Nykode Therapeutics

Poor diversification

The 3 months correlation between BioInvent and Nykode is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Nykode Therapeutics ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nykode Therapeutics ASA and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Nykode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nykode Therapeutics ASA has no effect on the direction of BioInvent International i.e., BioInvent International and Nykode Therapeutics go up and down completely randomly.

Pair Corralation between BioInvent International and Nykode Therapeutics

Assuming the 90 days trading horizon BioInvent International AB is expected to generate 1.47 times more return on investment than Nykode Therapeutics. However, BioInvent International is 1.47 times more volatile than Nykode Therapeutics ASA. It trades about 0.13 of its potential returns per unit of risk. Nykode Therapeutics ASA is currently generating about 0.1 per unit of risk. If you would invest  2,910  in BioInvent International AB on April 23, 2025 and sell it today you would earn a total of  1,050  from holding BioInvent International AB or generate 36.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

BioInvent International AB  vs.  Nykode Therapeutics ASA

BioInvent International

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BioInvent International AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, BioInvent International unveiled solid returns over the last few months and may actually be approaching a breakup point.

Nykode Therapeutics ASA

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nykode Therapeutics ASA are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite conflicting essential indicators, Nykode Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with BioInvent International and Nykode Therapeutics

The main advantage of trading using opposite BioInvent International and Nykode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Nykode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nykode Therapeutics will offset losses from the drop in Nykode Therapeutics' long position.

The idea behind BioInvent International AB and Nykode Therapeutics ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.